A phase I study of AEG35156 in combination with docetaxel in patients with solid tumors.
Phase of Trial: Phase I
Latest Information Update: 29 Mar 2016
At a glance
- Drugs AEG 35156 (Primary) ; Docetaxel
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 21 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Aug 2006 Status change
- 15 Feb 2006 New trial record.